未知股票 DECAU 深 沪
已收盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 876.00万
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 1.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Scilex Announces S-4 Effectiveness for Denali–Semnur Merger Proposal
Aug 13 (Reuters) - Denali Capital Acquisition Corp DNQAF.PK: SCILEX HOLDING COMPANY (NASDAQ: SCLX) ANNOUNCES EFFECTIVENESS OF REGISTRATION STATEMENT ON FORM S-4 FOR THE PROPOSED BUSINESS COMBINATION O...
2025-08-13 19:33
BRIEF-Denali Capital Shareholders Approve Extension For Business Combination Deadline
April 14 (Reuters) - Denali Capital Acquisition Corp DECA.O: DENALI CAPITAL ACQUISITION CORP. ANNOUNCES SHAREHOLDER APPROVAL OF EXTENSION OF DEADLINE TO COMPLETE BUSINESS COMBINATION DENALI CAPITAL AC...
2025-04-15 05:48
Denali Capital Delays 10-K Filing
Denali Capital Acquisition Corp. Class A ( ($DECA) ) has released a notificatio...
2025-04-01 20:24
BRIEF-Denali Capital Acquisition Announces Extension Of Deadline To Complete Business Combination
March 11 (Reuters) - Denali Capital Acquisition Corp DECA.O: DENALI CAPITAL ACQUISITION CORP. ANNOUNCES EXTENSION OF DEADLINE TO COMPLETE BUSINESS COMBINATION Source text: ID:nGNX3DDlsJ Further compan...
2025-03-12 06:15
单月IPO规模超10亿美元，医药企业上市全面转暖
转自：新康界 2024年9月，在生物医药领域，有7家公司采取IPO形式上市，5家公司SPAC合并上市。 一、IPO上市 9月是生物医药公司IPO的传统旺季，共有...
2024-10-28 17:51
快讯 | Denali Capital Acquisition：合并公司将更名为Semnur Pharmaceuticals, Inc.，普通股将在纳斯达克上市，逐笔明细代码为"Smnr"。
Denali Capital Acquisition: Combined Co to Be Renamed Semnur Pharmaceuticals, I...
2024-09-03 21:03
快讯 | Denali Capital Acquisition：Scilex预计在完成交易后成为合并公司的多数持有人
Denali Capital Acquisition: Scilex Expected to Be Majority Holder of Combined C...
2024-09-03 21:02
快讯 | Denali Capital Acquisition corp：Semnur的预交易股权价值为25亿美元
Denali Capital Acquisition Corp: Pre-Transaction Equity Value of Semnur at $2.5...
2024-09-03 21:01
快讯 | Semnur药业公司，Scilex控股公司的全资子公司，以及Denali Capital Acquisition Corp. (纳斯达克: Deca) 宣布签署拟议的业务合并协议。
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Compa...
2024-09-03 21:00
Scilex Holding files to sell up to 3.5M shares by holders
Scilex Holding (NASDAQ:SCLX) files preliminary prospectus to offer and sell, by the selling securityholders, of up to 3,500,000 shares of common stock. SEC Filing More on Scilex Holding Company Semnu...
2024-07-19 04:34
